ELZONRIS conc perf 1 mg/ml flac 1 ml
7680687970013
CH-68797
L01XX67
07.16.4.
Reimbursement limitations:
ELZONRIS.01
Le traitement par ELZONRIS nécessite une garantie de prise en charge par l'assureur-maladie après consultation …
1 / 3
google
Details
- Product number
- 6879701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- tagraxofuspum 1 mg, trometamolum, natrii chloridum, sorbitolum 50 mg, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 1 ml corresp. natrium 1.98 mg.
Articles (1)
Elzonris 1mg / ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
50.0 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.98 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 16973.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2024
Authorization holder
Stemline Therapeutics Switzerland GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 68797
- Drug name
- Elzonris 1mg / ml, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01XX67
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 03/02/2023
- Authorization expiration date
- 02/02/2028
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ELZONRIS conc perf 1 mg/ml flac 1 ml
- Description (DE)
- ELZONRIS Inf Konz 1 mg/ml Durchstf 1 ml
- Market launch
- 03/02/2023
- Narcotic (BTM)
- No